LAUSR

Ancochea, A., Alvarez-Larran, A., Morales-Indiano, C., Garcia-Pallarols, F., Martinez-Aviles, L., Angona, A., Senin, A., Bellosillo, B. & Besses, C. (2014) The role of serum erythropoietin level and JAK2 V617F allele burden in the diagnosis of polycythaemia vera. British Journal of Haematology, 167, 411–417. Barbui, T., Thiele, J., Vannucchi, A.M. & Tefferi, A. (2015) Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis. Blood Cancer Journal, 5, e337. Cleyrat, C., Jelinek, J., Girodon, F., Boissinot, M., Ponge, T., Harousseau, J.L., Issa, J.P. & Hermouet, S. (2010) JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5. Leukemia, 24, 1069–1073. Godfrey, A.L., Chen, E., Pagano, F., Ortmann, C.A., Silber, Y., Bellosillo, B., Guglielmelli, P., Harrison, C.N., Reilly, J.T., Stegelmann, F., Bijou, F., Lippert, E., McMullin, M.F., Boiron, J.M., Dohner, K., Vannucchi, A.M., Besses, C., Campbell, P.J. & Green, A.R. (2012) JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone. Blood, 120, 2704–2707. Langabeer, S.E., Andrikovics, H., Asp, J., Bellosillo, B., Carillo, S., Haslam, K., Kjaer, L., Lippert, E., Mansier, O., Oppliger Leibundgut, E., Percy, M.J., Porret, N., Palmqvist, L., Schwarz, J., McMullin, M.F., Schnittger, S., Pallisgaard, N. & Hermouet, S.; MPN&MPNr-EuroNet. (2015) Molecular diagnostics of myeloproliferative neoplasms. European Journal of Haematology, 95, 270–279. Ma, W., Kantarjian, H., Zhang, X., Yeh, C.H., Zhang, Z.J., Verstovsek, S. & Albitar, M. (2009) Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias. J Mol Diagn, 11, 49–53. McMullin, M.F., Bareford, D., Campbell, P., Green, A.R., Harrison, C., Hunt, B., Oscier, D., Polkey, M.I., Reilly, J.T., Rosenthal, E., Ryan, K., Pearson, T.C. & Wilkins, B.; General Haematology Task Force of the British Committee for Standards in Haematology. (2005) Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. British Journal of Haematology, 130, 174–195. Rapado, I., Grande, S., Albizua, E., Ayala, R., Hernandez, J.A., Gallardo, M., Gilsanz, F. & Martinez-Lopez, J. (2009) High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms. J Mol Diagn, 11, 155–161. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon. Wang, L., Swierczek, S.I., Lanikova, L., Kim, S.J., Hickman, K., Walker, K., Wang, K., Drummond, J., Doddapaneni, H., Reid, J.G., Muzny, D.M., Gibbs, R.A., Wheeler, D.A. & Prchal, J.T. (2014) The relationship of JAK2(V617F) and acquired UPD at chromosome 9p in polycythemia vera. Leukemia, 28, 938–941.